• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE 014; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRAVERSE 014; PTA BALLOON DILATATION CATHETER Back to Search Results
Catalog Number UNK ULTRAVERSE 014
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Perforation of Vessels (2135); Vascular Dissection (3160); Embolism/Embolus (4438)
Event Date 08/23/2021
Event Type  Injury  
Manufacturer Narrative
As the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.
 
Event Description
It was reported through an anonymous post-market survey of percutaneous transluminal angioplasty (pta) catheters that out of 443 total treatments, 2 were unsuccessful in renal, 7 were unsuccessful in femoral, 3 were unsuccessful in popliteal, 7 were unsuccessful in tibial, 156 were unsuccessful in peroneal and there were 7 occurrences of flow-limiting dissection, 5 occurrences of vessel perforation and 5 occurrences of distal embolization which required intervention.The current status of the patient(s) was not provided.
 
Event Description
It was reported through an anonymous post-market survey of percutaneous transluminal angioplasty (pta) catheters that out of two hundred and ninety-three total treatments, two were unsuccessful in renal, seven were unsuccessful in femoral, three were unsuccessful in popliteal, seven were unsuccessful in tibial, eleven were unsuccessful in peroneal and there were seven occurrences of flow-limiting dissection, five occurrences of vessel perforation and five occurrences of distal embolization which required intervention.The current status of the patient(s) was not provided.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not requested as the lot number reported as unknown.Investigation summary: the device was not returned for evaluation.Therefore, the investigation is inconclusive, as no objective evidence has been provided to confirm any alleged deficiency with the device.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAVERSE 014
Type of Device
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key12481266
MDR Text Key271702703
Report Number2020394-2021-01696
Device Sequence Number1
Product Code LIT
Combination Product (y/n)N
PMA/PMN Number
K121856
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 10/03/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK ULTRAVERSE 014
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received10/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-